Abstract
Recently, there have been reports of postnatal vasculogenesis in cases of ischaemia models. The aim of the present study is to provide evidence of postnatal vasculogenesis in breast-cancer-bearing mice. Based on cell surface antigen expression, we isolated endothelial precursor cells from bone marrow, peripheral blood and tumour-infiltrating cells from mice that had received six human breast cancer xenografts. In all three areas (bone marrow, peripheral blood and tumour-infiltrating cells), endothelial precursor cell population was elevated in all transplanted mice. Differentiation and migration activities of endothelial precursor cells were measured by comparing levels of the endothelial precursor cell maturation markers Flk-1, Flt-1, Tie2, VE-cadherin and CD31 among these three areas. The endothelial precursor cell population was 14% or greater in the gated lymphocyte-size fraction of the inflammatory breast cancer xenograft named WIBC-9, which exhibits a hypervascular structure and de novo formation of vascular channels, namely vasculogenic mimicry (Shirakawa et al, 2001). In vitro, bone marrow-derived endothelial precursor cells from four human breast cancer xenografts proliferated and formed multiple clusters of spindle-shaped attaching cells on a vitronectin-coated dish. The attaching cells, which incorporated DiI-labelled acetylated low-density lipoprotein (DiI-acLDL) and were negative for Mac-1. The putative bone marrow derived endothelial precursor cell subset, which was double positive of CD34 and Flk-1, and comparative bone marrow derived CD34 positive with Flk-1 negative subset were cultured. The former subset incorporated DiI-acLDL and were integrated with HUVECs. Furthermore, they demonstrated significantly higher levels of murine vascular endothelial growth factor and interleukin-8 in culture supernatant on time course by enzyme-linked immunosorbent assay. These findings constitute direct evidence that breast cancer induces postnatal vasculogenesis in vivo.
MeSH Terms
Animals
Antigens, CD34/biosynthesis
Bone Marrow/metabolism
Breast Neoplasms/blood supply
Disease Models, Animal
Endothelial Growth Factors/genetics,metabolism
Endothelium, Vascular/metabolism,pathology
Enzyme-Linked Immunosorbent Assay
Female
Granulocyte-Macrophage Colony-Stimulating Factor/pharmacology
Humans
In Vitro Techniques
Intercellular Signaling Peptides and Proteins/genetics,metabolism
Interleukin-8/metabolism
Lipoproteins, LDL/metabolism
Lymphokines/genetics,metabolism
Mice
Mice, Inbred BALB C
Mice, Nude
Neoplasm Transplantation
Neovascularization, Pathologic/metabolism,pathology
Receptors, Vascular Endothelial Growth Factor/metabolism
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factor Receptor-2/metabolism
Vascular Endothelial Growth Factors
Chemicals
Antigens, CD34
Endothelial Growth Factors
Intercellular Signaling Peptides and Proteins
Interleukin-8
Lipoproteins, LDL
Lymphokines
Vascular Endothelial Growth Factor A
Vascular Endothelial Growth Factors
Granulocyte-Macrophage Colony-Stimulating Factor
Receptors, Vascular Endothelial Growth Factor
Vascular Endothelial Growth Factor Receptor-2
Authors & Affiliations
10 authors, click to expand affiliations / ORCID
Shirakawa K
Pharmacology Division, National Cancer Center Research Institute, Tsukiji 5-1-1, Chuo-Ku, Tokyo 104-0045, Japan.
[email protected]
Furuhata S
Watanabe I
Hayase H
Shimizu A
Ikarashi Y
Yoshida T
Terada M
Hashimoto D
Wakasugi H
References (21)
21 references, click to expand
-
Clinical applications of angiogenic growth factors and their inhibitors.
Nat Med. 1999 Dec;5(12):1359-64
PMID: 10581076
-
In vivo assessment of vascular endothelial growth factor-induced angiogenesis.
Int J Cancer. 1999 Dec 10;83(6):798-802
PMID: 10597197
-
Transplantation of ex vivo expanded endothelial progenitor cells for therapeutic neovascularization.
Proc Natl Acad Sci U S A. 2000 Mar 28;97(7):3422-7
PMID: 10725398
-
Transplanted cord blood-derived endothelial precursor cells augment postnatal neovascularization.
J Clin Invest. 2000 Jun;105(11):1527-36
PMID: 10841511
-
Soluble Flt-1 gene therapy for peritoneal metastases using HVJ-cationic liposomes.
Gene Ther. 2000 Jun;7(12):1027-33
PMID: 10871751
-
Absence of endothelial cells, central necrosis, and fibrosis are associated with aggressive inflammatory breast cancer.
Cancer Res. 2001 Jan 15;61(2):445-51
PMID: 11212228
-
Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.
J Exp Med. 2001 May 7;193(9):1005-14
PMID: 11342585
-
Mobilized human CD34+ hematopoietic stem cells enhance tumor growth in a nonobese diabetic/severe combined immunodeficient mouse model of human non-Hodgkin's lymphoma.
Cancer Res. 2001 Oct 15;61(20):7654-9
PMID: 11606408
-
Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer.
Int J Cancer. 2002 May 20;99(3):344-51
PMID: 11992402
-
VEGF regulates haematopoietic stem cell survival by an internal autocrine loop mechanism.
Nature. 2002 Jun 27;417(6892):954-8
PMID: 12087404
-
Angiogenic factors.
Science. 1987 Jan 23;235(4787):442-7
PMID: 2432664
-
Inhibition of vascular endothelial cell growth factor activity by an endogenously encoded soluble receptor.
Proc Natl Acad Sci U S A. 1993 Nov 15;90(22):10705-9
PMID: 8248162
-
Endostatin: an endogenous inhibitor of angiogenesis and tumor growth.
Cell. 1997 Jan 24;88(2):277-85
PMID: 9008168
-
Isolation of putative progenitor endothelial cells for angiogenesis.
Science. 1997 Feb 14;275(5302):964-7
PMID: 9020076
-
United Kingdom Co-ordinating Committee on Cancer Research (UKCCCR) Guidelines for the Welfare of Animals in Experimental Neoplasia (Second Edition).
Br J Cancer. 1998;77(1):1-10
PMID: 9459138
-
Paracrine expression of a native soluble vascular endothelial growth factor receptor inhibits tumor growth, metastasis, and mortality rate.
Proc Natl Acad Sci U S A. 1998 Jul 21;95(15):8795-800
PMID: 9671758
-
Viral vector-targeted antiangiogenic gene therapy utilizing an angiostatin complementary DNA.
Cancer Res. 1998 Aug 1;58(15):3362-9
PMID: 9699667
-
Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularization.
Nat Med. 1999 Apr;5(4):434-8
PMID: 10202935
-
Angiogenesis and vasculogenesis as therapeutic strategies for postnatal neovascularization.
J Clin Invest. 1999 May;103(9):1231-6
PMID: 10225965
-
Vessel cooption, regression, and growth in tumors mediated by angiopoietins and VEGF.
Science. 1999 Jun 18;284(5422):1994-8
PMID: 10373119
-
VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells.
EMBO J. 1999 Jul 15;18(14):3964-72
PMID: 10406801